Wells Fargo’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-21,221
| Closed | -$2.06M | – | 6997 |
|
|
2019
Q3 | $2.06M | Buy |
21,221
+996
| +5% | +$99.7K | ﹤0.01% | 3309 |
|
|
2019
Q2 | $2.07M | Sell |
20,225
-77
| -0.4% | -$8.31K | ﹤0.01% | 3333 |
|
|
2019
Q1 | $2.31M | Sell |
20,302
-30,537
| -60% | -$2.24M | ﹤0.01% | 3237 |
|
|
2018
Q4 | $1.99M | Buy |
50,839
+3,075
| +6% | +$133K | ﹤0.01% | 3267 |
|
|
2018
Q3 | $2.61M | Sell |
47,764
-118,561
| -71% | -$8.11M | ﹤0.01% | 3189 |
|
|
2018
Q2 | $13.8M | Sell |
166,325
-16,782
| -9% | -$1.3M | ﹤0.01% | 1807 |
|
|
2018
Q1 | $12.2M | Sell |
183,107
-70,456
| -28% | -$4.07M | ﹤0.01% | 1836 |
|
|
2017
Q4 | $13M | Sell |
253,563
-223,187
| -47% | -$16M | ﹤0.01% | 1801 |
|
|
2017
Q3 | $42.5M | Sell |
476,750
-593
| -0.1% | -$45K | 0.01% | 958 |
|
|
2017
Q2 | $28.5M | Sell |
477,343
-45,551
| -9% | -$2.55M | 0.01% | 1169 |
|
|
2017
Q1 | $27.9M | Buy |
522,894
+297,277
| +132% | +$17.6M | 0.01% | 1193 |
|
|
2016
Q4 | $11.3M | Buy |
225,617
+91,286
| +68% | +$4.89M | ﹤0.01% | 1756 |
|
|
2016
Q3 | $8.07M | Buy |
134,331
+111,559
| +490% | +$6.43M | ﹤0.01% | 1910 |
|
|
2016
Q2 | $1.16M | Buy |
22,772
+17,340
| +319% | +$741K | ﹤0.01% | 3386 |
|
|
2016
Q1 | $160K | Sell |
5,432
-1,060
| -16% | -$33.4K | ﹤0.01% | 4548 |
|
|
2015
Q4 | $294K | Sell |
6,492
-115,217
| -95% | -$6.04M | ﹤0.01% | 4230 |
|
|
2015
Q3 | $5.08M | Sell |
121,709
-109,779
| -47% | -$5.73M | ﹤0.01% | 2318 |
|
|
2015
Q2 | $14M | Sell |
231,488
-74,330
| -24% | -$4.91M | 0.01% | 1641 |
|
|
2015
Q1 | $23.7M | Buy |
+305,818
| New | +$17.6M | 0.01% | 1220 |
|
Wells Fargo's ONCE Position: Q4 2019 in Review
Wells Fargo sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 21,221 shares — an estimated $2.06M sold.
Wells Fargo first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $42.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Wells Fargo reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 21,221 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.06M.
- Wells Fargo first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- Wells Fargo's Spark Therapeutics, Inc. Common Stock position peaked at $42.5M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.